NCT07609810

Palmitoylethanolamide in Ulcerative Colitis

RecruitingNAINTERVENTIONAL

Trial Details

Start: 2026-07-15Est. Completion: 2028-12-15

Enrollment target: 60 participants

Locations

Internal Medicine and Gastroenterology clinic, El-Demerdash Hospital, Cairo, El-Abbasia, Egypt

Contact

Ulcerative Colitis (UC)

The purpose of this phase III, multicenter, double-blind, placebo-controlled study is to evaluate the efficacy and safet…

Guangzhou, ChinaEst. completion May 2028

Ulcerative Colitis

This study, A3921210 is designed to evaluate the efficacy, safety and pharmacokinetics (PK) of tofacitinib in pediatric …

Los Angeles, United StatesEst. completion Apr 14, 2027

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.